Novartis AG (NVS) Stock Price Today
Overview
Financial
Technicals
Analysis
Corporate Action
About
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Technical Indicators
|
|
|
Bearish (7)
Neutral (7)
Bullish (13)
Performance
NVS ROI
% from 52W High
52W Low: $92.57
18 Apr 2024
52W High: $120.89
30 Aug 2024
News
People Also Bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions
Let’s trade or invest in this asset by signing up or logging in!
You can also download our app!
